Protocol for a feasibility study of smoking cessation in the surgical pathway before major lung surgery: Project MURRAY

Sebastian T Lugg, Amy Kerr, Salma Kadiri, Alina-Maria Budacan, Amanda Farley, Olga Perski, Robert West, Jamie Brown, David R Thickett, Babu Naidu, Project MURRAY Investigators, Michael Shackcloth, Sarah Feeney, Lindsey Murphy, Magenta Black, Sridhar Rathinam, Rebecca Boyles, Syed Qadri, Karen Dobbs, Helen Shackleford, Zara Jalal, Christine Jordan, Ben Skirth, Sebastian T Lugg, Amy Kerr, Salma Kadiri, Alina-Maria Budacan, Amanda Farley, Olga Perski, Robert West, Jamie Brown, David R Thickett, Babu Naidu, Project MURRAY Investigators, Michael Shackcloth, Sarah Feeney, Lindsey Murphy, Magenta Black, Sridhar Rathinam, Rebecca Boyles, Syed Qadri, Karen Dobbs, Helen Shackleford, Zara Jalal, Christine Jordan, Ben Skirth

Abstract

Introduction: Smoking prior to major thoracic surgery is the biggest risk factor for development of postoperative pulmonary complications, with one in five patients continuing to smoke before surgery. Current guidance is that all patients should stop smoking before elective surgery yet very few are offered specialist smoking cessation support. Patients would prefer support within the thoracic surgical pathway. No study has addressed the effectiveness of such an intervention in this setting on cessation. The overall aim is to determine in patients who undergo major elective thoracic surgery whether an intervention integrated (INT) into the surgical pathway improves smoking cessation rates compared with usual care (UC) of standard community/hospital based NHS smoking support. This pilot study will evaluate feasibility of a substantive trial.

Methods and analysis: Project MURRAY is a trial comparing the effectiveness of INT and UC on smoking cessation. INT is pharmacotherapy and a hybrid of behavioural support delivered by the trained healthcare practitioners (HCPs) in the thoracic surgical pathway and a complimentary web-based application. This pilot study will evaluate the feasibility of a substantive trial and study processes in five adult thoracic centres including the University Hospitals Birmingham NHS Foundation Trust. The primary objective is to establish the proportion of those eligible who agree to participate. Secondary objectives include evaluation of study processes. Analyses of feasibility and patient-reported outcomes will take the form of simple descriptive statistics and where appropriate, point estimates of effects sizes and associated 95% CIs.

Ethics and dissemination: The study has obtained ethical approval from NHS Research Ethics Committee (REC number 19/WM/0097). Dissemination plan includes informing patients and HCPs; engaging multidisciplinary professionals to support a proposal of a definitive trial and submission for a full application dependent on the success of the study.

Trial registration number: NCT04190966.

Keywords: adult anaesthesia; adult thoracic medicine; cardiothoracic surgery.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Figures

Figure 1
Figure 1
Trial schema. INT, intervention integrated; UC, usual care.

References

    1. SCTS National thoracic surgery activity and outcomes report, 2018. Available: [Accessed Jun 2020].
    1. Agostini P, Lugg ST, Adams K, et al. . Postoperative pulmonary complications and rehabilitation requirements following lobectomy: a propensity score matched study of patients undergoing video-assisted thoracoscopic surgery versus thoracotomy†. Interact Cardiovasc Thorac Surg 2017;24:931–7. 10.1093/icvts/ivx002
    1. Agostini P, Cieslik H, Rathinam S, et al. . Postoperative pulmonary complications following thoracic surgery: are there any modifiable risk factors? Thorax 2010;65:815–8. 10.1136/thx.2009.123083
    1. Lugg ST, Tikka T, Agostini PJ, et al. . Smoking and timing of cessation on postoperative pulmonary complications after curative-intent lung cancer surgery. J Cardiothorac Surg 2017;12:52. 10.1186/s13019-017-0614-4
    1. Parsons A, Daley A, Begh R, et al. . Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010;340:b5569. 10.1136/bmj.b5569
    1. NICE Smoking: acute acute maternity and mental health services. Public Health Guideline [PH48], 2013. Available: [Accessed Jun 2020].
    1. Thomsen T, Villebro N, Møller AM. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev 2014;3:CD002294. 10.1002/14651858.CD002294.pub4
    1. Møller AM, Villebro N, Pedersen T, et al. . Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002;359:114–7. 10.1016/S0140-6736(02)07369-5
    1. Lindström D, Sadr Azodi O, Wladis A, et al. . Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial. Ann Surg 2008;248:739–45. 10.1097/SLA.0b013e3181889d0d
    1. Webb JKA, Thickett D, Naidu B. Smoking habits of pre-surgery patients. ERJ 2015;46:PA2511.
    1. Warner DO, Klesges RC, Dale LC, et al. . Telephone quitlines to help surgical patients quit smoking patient and provider attitudes. Am J Prev Med 2008;35:S486–93. 10.1016/j.amepre.2008.08.032
    1. Lee SM, Landry J, Jones PM, et al. . Long-term quit rates after a perioperative smoking cessation randomized controlled trial. Anesth Analg 2015;120:582–7. 10.1213/ANE.0000000000000555
    1. Farley A, Aveyard P, Kerr A, et al. . Surgical lung cancer patients’ views about smoking and support to quit after diagnosis: a qualitative study. J Cancer Surviv 2016;10:312–9. 10.1007/s11764-015-0477-4
    1. Park ER, Japuntich S, Temel J, et al. . A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial. J Thorac Oncol 2011;6:1059–65. 10.1097/JTO.0b013e318215a4dc
    1. Rice VH, Heath L, Livingstone-Banks J, et al. . Nursing interventions for smoking cessation. Cochrane Database Syst Rev 2017;12:CD001188. 10.1002/14651858.CD001188.pub5
    1. NICE Lung cancer: diagnosis and management. NICE Guideline [CG121], 2011. Available: [Accessed Jun 2020].
    1. NHS National cancer waiting times monitoring dataset guidance – version 9.0, 2015. Available: [Accessed Jun 2020].
    1. Thornton L, Quinn C, Birrell L, et al. . Free smoking cessation mobile apps available in Australia: a quality review and content analysis. Aust N Z J Public Health 2017;41:625–30. 10.1111/1753-6405.12688
    1. McBride CM, Ostroff JS. Teachable moments for promoting smoking cessation: the context of cancer care and survivorship. Cancer Control 2003;10:325–33. 10.1177/107327480301000407
    1. Shi Y, Warner DO. Surgery as a teachable moment for smoking cessation. Anesthesiology 2010;112:102–7. 10.1097/ALN.0b013e3181c61cf9
    1. Hemming K, Haines TP, Chilton PJ, et al. . The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting. BMJ 2015;350:h391. 10.1136/bmj.h391
    1. Scrum Alliance. The Scrum Guide, 2017. Available: [Accessed Jun 2020].
    1. Strategy AM. Implementation, organisation and people. Springer Verlag, 2015.
    1. Michie S, Hyder N, Walia A, et al. . Development of a taxonomy of behaviour change techniques used in individual behavioural support for smoking cessation. Addict Behav 2011;36:315–9. 10.1016/j.addbeh.2010.11.016
    1. NCSCT Standard treatment programme, 2012. Available: [Accessed Jun 2020].
    1. West R, Sohal T. “Catastrophic” pathways to smoking cessation: findings from national survey. BMJ 2006;332:458–60. 10.1136/
    1. Ong KC, Cheong GN, Prabhakaran L, et al. . Predictors of success in smoking cessation among hospitalized patients. Respirology 2005;10:63–9. 10.1111/j.1440-1843.2005.00656.x
    1. Sivarajan Froelicher ES, Miller NH, Christopherson DJ, et al. . High rates of sustained smoking cessation in women hospitalized with cardiovascular disease: the women's initiative for nonsmoking (wins). Circulation 2004;109:587–93. 10.1161/01.CIR.0000115310.36419.9E
    1. BTS Recommendations for hospital smoking cessation services for commisioners and health care professionals, 2012. Available: [Accessed Jun 2020].
    1. NCSCT Electronic cigarettes - a briefing for stop smoking services, 2016. Available: [Accessed Jun 2020].
    1. ESTS Database annual report: silver book, 2015. Available: [Accessed Jun 2020].
    1. Seely AJE, Ivanovic J, Threader J, et al. . Systematic classification of morbidity and mortality after thoracic surgery. Ann Thorac Surg 2010;90:936–42. 10.1016/j.athoracsur.2010.05.014
    1. Abbott TEF, Fowler AJ, Pelosi P, et al. . A systematic review and consensus definitions for standardised end-points in perioperative medicine: pulmonary complications. Br J Anaesth 2018;120:1066–79. 10.1016/j.bja.2018.02.007
    1. Heatherton TF, Kozlowski LT, Frecker RC, et al. . The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict 1991;86:1119–27. 10.1111/j.1360-0443.1991.tb01879.x
    1. West R, Hajek P. Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology 2004;177:195–9. 10.1007/s00213-004-1923-6
    1. EuroQol Group EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199–208. 10.1016/0168-8510(90)90421-9
    1. Morse JM. Analytic strategies and sample size. Qual Health Res 2015;25:1317–8. 10.1177/1049732315602867
    1. Billingham SAM, Whitehead AL, Julious SA. An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom clinical research network database. BMC Med Res Methodol 2013;13:104. 10.1186/1471-2288-13-104
    1. Browne RH. On the use of a pilot sample for sample size determination. Stat Med 1995;14:1933–40. 10.1002/sim.4780141709

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe